Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Surveillance to Evaluate the Safety and Effectiveness of Upadacitinib in Korean Patients

NCT04541810 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04541810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04541810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Surveillance to Evaluate the Safety and Effectiveness of Upadacitinib in Korean Patients
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
January 26, 2021
Completion date
December 31, 2025
Enrollment
2,369 (actual)
Sites
116

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis (as), atopic dermatitis (ad), psoriatic arthritis (psa), rheumatoid arthritis (ra)